Formulation and Evaluation of Transdermal Patches of Labetalol Hydrochloride for Sustained Release

Authors

  • Kallepalli Padma Kranthi, Praveen Gujjula , Dr. D Raghava, Dr. Kavala Nageswara Rao Author

DOI:

https://doi.org/10.48047/

Keywords:

Labetalol Hydrochloride, Transdermal Patches, Sustained Release, Hypertension, Solvent Casting, Permeation Enhancer, Drug Release Kinetics.

Abstract

Transdermal drug delivery systems (TDDS) have gained significant attention for their ability to deliver drugs in a controlled manner, improve patient compliance, and bypass first-pass metabolism. Labetalol hydrochloride

Downloads

Download data is not yet available.

References

Frishman, W.H. (1996). Labetalol: Pharmacology and Clinical Use. American Heart Journal, 131(2), 363–370.

Gupta, S., et al. (2013). Formulation and Evaluation of Ethyl Cellulose Based Transdermal Patches of Labetalol Hydrochloride. International Journal of Pharmaceutical Sciences and Research, 4(9), 3517–3523.

Downloads

Published

2025-10-07

How to Cite

Kallepalli Padma Kranthi, Praveen Gujjula , Dr. D Raghava, Dr. Kavala Nageswara Rao. (2025). Formulation and Evaluation of Transdermal Patches of Labetalol Hydrochloride for Sustained Release . History of Medicine, 11(2), 119-134. https://doi.org/10.48047/